This month we are pleased to devote our GBCHealth Insights deep-dive newsletter to the Global Fund to Fight AIDS, Tuberculosis and Malaria. Over the past decade, the Global Fund has helped save millions of lives around the world, and the private sector has played a vital role in this private-public partnership. The Private Sector Delegation (PSD) is a group of companies that brings the business voice to the Global Fund, and GBCHealth serves as the “Focal Point,” managing the PSD’s collaboration with the Fund.
In this issue, we hear insights from Paul Schaper of Merck, the Global Fund’s new Private Sector voting Board member, and from Dr. Brian Brink of Anglo American, whose term as Private Sector voting Board member recently expired. Brink has a long history with the Fund, dating back to its very first Board meeting more than a decade ago. In addition, as the Global Fund gears up to raise USD 15 billion from donors to fund its work for the years 2014-2016, GBCHealth’s Whitney White gives a “Replenishment 101” primer on why the Fund’s Fourth Replenishment is so critical and how it works.
The Global Fund and Private Sector to Prioritize Country-Level Partnerships
by Paul Schaper, Executive Director, Global Public Policy, Merck &Co.; Private Sector Board Member, Global Fund to Fight AIDS, Tuberculosis and Malaria Board.
The Global Fund was conceived as a public-private partnership that brings governments, civil society, private foundations, and the private sector together to address the epidemics of HIV, TB, and malaria. Merck has been pleased to be an active member of the Global Fund Private Sector Delegation since its inception as part of its ongoing corporate engagement in HIV and I am honored to have been selected by the PSD as its new Board member.
As a member of the Global Fund’s governance Board, the Private Sector Delegation has been committed to the idea that private sector businesses have key skills, technical expertise, and human resources that can be brought to bear to help the Global Fund successfully fight against HIV/AIDS, TB and malaria.
In addition to contributing directly to help the Global Fund meet its USD 15 billion target for the upcoming Fourth Replenishment, the private sector can play a critical role helping the Fund achieve heightened impact on the ground.
Read Paul Schaper's full piece here.
Q&A with Brian Brink: A Decade of Bringing the Private Sector Voice to the Global Fund
In June 2013, Dr. Brian Brink sat at a table in Sri Lanka and cast his last vote as a Board member of the Global Fund to Fight AIDS, Tuberculosis and Malaria. Brink, who represented the Private Sector Delegation, has missed just two of the Board’s 29 meetings since the Fund began over a decade ago. In this Q&A with GBCHealth, Brink describes how very far the private sector has come in earning the trust and respect of the Fund and the constituencies that make up its Board. He recalls the greatest challenges and accomplishments, calls on the private sector to significantly step up its cash contributions to the Fund during its upcoming replenishment and offers sage advice to his successor, Paul Schaper of Merck.
Brink is Chief Medical Officer at Anglo American, long considered a private sector leader in responding to TB and HIV. In 2002, as HIV was sweeping through South Africa and Anglo American, the mining company became one of the first major employers to offer free HIV testing to all of its employees and free antiretroviral medication to HIV-positive employees and their families.
“Most of you that have actual company programs in some way related to HIV/AIDS owe a debt to Brian Brink,” said Laurie Garrett, Senior Fellow for Global Health at the Council on Foreign Relations, when introducing Brink at the GBCHealth Conference in May. “He really created the template for how corporate responsibility could translate into directly providing HIV and tuberculosis services not only to your employees but to their families, their sex partners and on and on outwards.”
Known internationally as one of the most passionate and eloquent advocates for private sector engagement in the fight against HIV, TB and malaria, Brink argues in this Q&A that business not only has a moral imperative to contribute to the Global Fund but that it also makes good business sense. “It’s not a donation, it’s an investment,” Brink says. “And it’s an investment for the future of business success in emerging markets. If we can remove the burden of disease, we will liberate the economies and create the new markets that the private sector needs to grow.”
We hope you enjoy the reflections of one of the longest serving Global Fund Board members.
Q: What do you consider to be the PSD’s most significant accomplishments?
When we started out, for the private sector to be working in partnership with governments and civil society and all have a place on the same Board was unusual. Although everyone shared common purpose and vision for what the Global Fund was going to achieve, I don’t think that the relationships between the partners had been built or that the levels of trust required to work together were there, particularly in relation to the pharmaceutical industry. In fact, there was a great deal of mistrust of the pharmaceutical manufacturers as partners on the Global Fund Board. And so over the years, we had to build a private sector position where we would be recognized as trusted partners and contributors to the Fund. So it was an interesting challenge over the years. We’re now regarded as a really important element of the governance structure of the Global Fund. Over the years, we’ve built that recognition, trust and respect.
Read full Q&A.
The Global Fund's Fourth Replenishment: 101
The Global Fund to Fight AIDS, Tuberculosis and Malaria provides grants to low- and middle-income countries to fund prevention, treatment and care programs for HIV/AIDS, TB and malaria. In 2003, the Global Fund adopted a three-year replenishment model to assure countries of sustained and predictable financial support for their programs. The Third Voluntary Replenishment resulted in $10.4 billion for 2011-2013 programs. The goal for the upcoming Fourth Voluntary Replenishment is $15 billion from donors to fund grant programs for the next three years.
GBCHealth’s Whitney White, who coordinates the Private Sector Delegation as its “Focal Point,” explains everything you need to know about it in her “Replenishment 101” primer.
Read Replenishment 101.
PSD Companies in Action
Beyond financial contributions, the private sector can contribute to the work and success of the Global Fund in many ways. Companies can act as commercial suppliers of commodities and services to the Global Fund and its grant recipients, co-invest in grant-funded projects, improve the health systems in which the projects operate and provide technical expertise. The Coca-Cola Company, for example, used its unique skills in supply chain distribution to improve the drug distribution system in Tanzania to get medicines to rural areas and Standard Bank gave grant recipients financial training. The case studies below, featuring the work of PSD members Chevron, Novartis, Sanofi and SABMiller, offer a few examples of how the private sector can partner with the Global Fund and “invest for impact.”
Chevron: The First Global Fund Corporate Champion
Novartis and Sanofi Increase Access to Malaria Drugs
SABMiller's Tavern Talk Saves Lives
GBCHealth Re-Elected to Third Term as the Global Fund Private Sector Delegation's Focal Point
The Private Sector Delegation to the Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria has re-elected GBCHealth as Focal Point for a new three-year term starting in June 2013. GBCHealth is pleased to continue in this important role that facilitates private sector participation in Global Fund strategy development and governance. GBCHealth’s Whitney White manages the Focal Point activities and can be reached at firstname.lastname@example.org. Read more about GBCHealth’s re-appointment here.
Fourth Replenishment Featured at GBCHealth's Annual Conference
GBCHealth’s 2013 Annual Conference in May featured a special session on private sector opportunities in the Fourth Replenishment. Moderated by Laurie Garrett, Senior Fellow at the Council on Foreign Relations, the conversation featured Dr. Mark Dybul, Global Fund Executive Director; Ambassador Eric Goosby, U.S. Global AIDS Coordinator; and Dr. Brian Brink, Chief Medical Officer at Anglo American plc and then-Board Member for the Global Fund’s Private Sector Delegation. Speakers emphasized the critical role the private sector can play in the replenishment and challenged the world’s corporations to contribute 10 percent of the $15 billion goal. Read the session summary and watch its video here.
Conversation with Global Fund's New Executive Director Mark Dybul
As part of its ongoing Expert Connections Webinars, GBCHealth hosted in April 2013, Global Fund Executive Director Dr. Mark Dybul in conversation with Dr. Brian Brink of Anglo American plc. Dybul explained his vision for the Global Fund, reviewed the 2013 priorities and the New Funding Model and stressed the crucial role of the private sector in achieving the Global Fund’s mission. Over 70 attendees from 46 different companies and organizations joined the popular webinar. Listen to the audio recording here.
PSD Newsletter Keeps Members Abreast of Global Fund News and Events
The Global Fund Private Sector Delegation publishes three newsletters a year to keep companies abreast of key Global Fund developments and private sector actions. Read the July edition here.
To read more about the Global Fund Board’s Private Sector Delegation (PSD), visit GBCHealth’s website here. If your company is interested in learning more or becoming engaged with the PSD, contact PSD Focal Point Whitney White at email@example.com